CD163 and neoplasm: For example, in lung adenocarcinoma in mice, it was demonstrated that the bacteria Diaphorobacter nitroreducens, when combined with oxaliplatin, increased the number of CD163- and CD68-positive macrophages while reducing Treg cells (CD4 FOXP3), thus slowing tumor progression [204].